Loss of E-cadherin does not affect F-actin enrichment in control conditions. Labeling reveals actin enrichment at the initiation stage (8ts) (open arrowheads) of controls (n = 3) and Cdh1^f/f; Crect^Tg/0 mutants (n = 2) treated with DMSO. Gamma of images adjusted to 2. MNP, medial nasal process; LNP, lateral nasal process. Scale bar, 20 μm.